or
forgot password
  • cancer clinical trials in san francisco, CA

  • Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer
    University of California San Francisco
    San Francisco, California 941104206
    Early Stage Breast Cancer
    Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
    University of California San Francisco
    San Francisco, California 941104206
    Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer
    Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
    Northern California Melanoma Center/ St. Mary's Medical Center
    San Francisco, California 94117
    Melanoma
    Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer
    A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
    University of California San Francisco
    San Francisco, California 941104206
    Multiple Myeloma
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent, Neuropathy
    Study of Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Diffuse Large Cell Lymphoma Relapsed/Refractory
    Characterization and Treatment of Chemotherapy Neuropathy
    University of California
    San Francisco, California 94108
    Chemotherapy-induced Neuropathy
    Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
    UCSF Carol Franc Buck Breast Care Center
    San Francisco, California 94115
    Malignant Neoplasm of Breast, Breast Radiotherapy, Breast Diseases, Ductal Breast Carcinoma, Intraoperative Radiotherapy
    Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
    University of California, Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Non-small Cell Lung Cancer Metastatic, Small Cell Lung Carcinoma
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    University of California San Francisco UCSF (SC)
    San Francisco, California
    Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme
    Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer
    California Pacific Medical Center Research Institute
    San Francisco, California 94115
    Prostate Cancer
    Phase II Intratumoral pIL-12 Electroporation in Cutaneous Lymphoma
    UCSF Helen Diller Comprehensive Cancer Center
    San Francisco, California 94143
    Cutaneous T Cell Lymphomas (CTCL), Mycosis Fungoides (MF)
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    University of California San Francisco
    San Francisco, California 941104206
    Cushing's Disease
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    California Pacific Medical Center Research Institute
    San Francisco, California 94115
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Neuroblastoma Biology Study
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Metastatic Castration-resistant Prostate Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect, Congenital Immunodeficiency, Metabolic Disease, Severe Immune Dysregulation
    Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Metastatic Breast Cancer
    Study of MLN8237 in Combination With Irinotecan and Temozolomide
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Neuroblastoma
    A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    University of California San Francisco UCSF 3
    San Francisco, California 94101
    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC) Patients Who Are Resistant or Ineligible/Intolerant to Platinum-based Chemotherapy., Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
    Pacific Hematology Oncology Associates
    San Francisco, California 94115
    Colorectal Cancer
    Adult-to-Adult Living Donor Transplant Cohort Study
    University of California
    San Francisco, California 94108
    Liver Diseases, Hepatocellular Cancer, End Stage Liver Disease, Hepatitis C, Liver Cirrhosis
    Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load
    University of California, San Francisco
    San Francisco, California 94143
    Human T-cell Leukemia Virus Type 1 Infection
    A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Castration Resistant Prostate Cancer
    Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
    University of California
    San Francisco, California 94108
    Transplantation, Liver
    Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months
    University of California, San Francisco
    San Francisco, California 94143
    Cigarette Smoking, Nicotine Dependence
    Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Endometrial Cancer
    A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
    University of California San Francisco Dept of Oncology
    San Francisco, California 94101
    Prostatic Neoplasms
    Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
    UCSF-Mount Zion
    San Francisco, California 94115
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
    Call for Information (Investigational Site 0263)
    San Francisco, California 94115
    Genital Warts, Anal Cancer, Anal Intraepithelial Neoplasia
    Reference Group Trial for The ONE Study
    Connie Frank Transplant Center
    San Francisco, California 94143
    End-stage Renal Failure, Kidney Graft Rejection
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    California Pacific Medical Center

    Trial Locations
    California Pacific Medical Center
    Kaiser Permanente-San Francisco
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    TELESTAR (Telotristat Etiprate for Somatostatin Analogue Refractory Carcinoid Syndrome)
    Lexicon Investigational Site
    San Francisco, California 94115
    Carcinoid Syndrome
    Countering Young Adult Tobacco Marketing in Bars
    University of California, San Francisco
    San Francisco, California 94143
    Smoking Cessation
    Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
    University of California, San Francisco
    San Francisco, California 94143
    Hepatocellular Carcinoma
    Neoadjuvant BKM120 in High-risk Prostate Cancer
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    High Risk Prostate Cancer
    A Phase III Study of Oral LDE225 Versus (vs) Temozolomide (TMZ) in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
    University of California San Francisco Dept of Pediatic Oncology
    San Francisco, California 94101
    Medulloblastoma
    Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Focal Treatment of Cervical Precancer
    University of California, San Francisco
    San Francisco, California 94143
    High-grade Cervical Intraepithelial Neoplasia
    Lenalidomide and Monoclonal Antibody With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
    University of California San Francisco
    San Francisco, California 941104206
    Non-HPV Locally Advanced Head and Neck Cancer
    A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer
    University of California, San Francisco
    San Francisco, California 94143
    Castrate-resistant Prostate Cancer Patients.
    A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases
    University of San Francisco, California
    San Francisco, California 94115
    BRAFV600E Melanoma Patients
    Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Unspecified Childhood Solid Tumor, Protocol Specific
    Belatacept Early Steroid Withdrawal Trial
    California Pacific Medical Center
    San Francisco, California 94115
    Renal Transplantation
    Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
    University of California, San Francisco
    San Francisco, California 94143
    Brain Metastases
    Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma
    San Francisco Oncology Associates
    San Francisco, California 94115
    Metastatic Melanoma
    Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia
    UCSF School of Medicine
    San Francisco, California 94143-0106
    Relapsed Acute Lymphoblastic Leukemia, Relapsed Acute Myelogenous Leukemia
    Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
    University of California San Francisco Dept of Pediatic Oncology
    San Francisco, California 94101
    Malignant Rhabdoid Tumors (MRT), Neuroblastoma
    Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
    Interventional Endoscopy Services
    San Francisco, California 94115
    Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract
    Early Diagnosis of Pulmonary Nodules
    California Pacific Medical Center
    San Francisco, California 94115
    Precancerous Conditions, Carcinoma
    Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
    California Pacific Medical Center
    San Francisco, California 94115
    Pancreatic Mass, Abnormal Lymph Nodes, Mediastinal Masses, Gastric Submucosal Masses
    The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
    University of California San Francisco (UCSF) Medical Center
    San Francisco, California 94115
    Prostate Cancer
    A Randomized Phase 2 Trial of Combining Sipuleucel-T With Immediate vs. Delayed CTLA-4 Blockade for Prostate Cancer
    University of California San Francisco
    San Francisco, California 941104206
    Prostate Cancer
    Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
    University of California, San Francisco - Mount Zion
    San Francisco, California 94115
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Multi-center Study Of Neurocognitive Outcomes In Patients With Brain Metastases Treated With Gamma Knife (GK)
    University of California, San Francisco
    San Francisco, California 94143
    Brain Metastases
    Phase 2 Study of the Monoclonal Antibody MGAH22(Margetuximab)in Patients With Relapsed or Refractory Advanced Breast Cancer
    University of California San Francisco
    San Francisco, California 941104206
    Breast Cancer
    Breast Cancer Risk Reduction: A Patient Doctor Intervention
    University of California, San Francisco Mt. Zion campus

    Trial Locations
    University of California, San Francisco Mt. Zion campus
    San Francisco General Hospital (SFGH)
    Breast Cancer
    iCAT for Recurrent/Refractory/HR Solid Tumors
    University of California, San Francisco
    San Francisco, California 94143
    Pediatric Solid Tumor, Sarcoma, Neuroblastoma, Wilms Tumor
    Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
    Pacific Hematology Oncology Associates
    San Francisco, California 94115
    Hodgkin Disease